National Drug Code Directory

Similar documents
National Drug Code Directory

Content of Labeling/Product Data Elements SPL Technical Errors Training ebook

Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act. Guidance for Industry

Guidance for Industry

CENTER FOR DRUG EVALUATION AND RESEARCH Orig1s000

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC

IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013

Guidance for Industry

Guidance for Industry

Guidance for Industry Labeling for Bronchodilators: Cold, Cough, Allergy, Bronchodilator,

Recommended Warning for Overthe-Counter. Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions

OV E R V I E W A N D G U I D A N C E O N VACC I N E 2 D B A R CO D I N G

Guidance for Industry

Establishment Registration SPL Technical Errors Training ebook

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products

NDA NDA APPROVAL

Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice

Guidance for Industry Bar Code Label Requirements Questions and Answers

On May 8 and 9, 2014, FDA held a public workshop on the development of initial standards for

NDA /S-008 SUPPLEMENT APPROVAL

Guidance for Industry

Average Sale Price (ASP) Data Collection Template/Data Validation Macro User Manual

Members covered under the Extended Family Planning (EFP) plan may not be eligible for all services. EFP is not a comprehensive benefit package.

Coding Systems. Understanding NDC and HCPCS. December 2014

Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation

Food and Drug Administration

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers

Application Submitted on Received on Supplement type NDA /S-005 July 24, 2008 July 25, 2008 Changes Being Effected

Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry

February 2006 Procedural

Inspections, Compliance, Enforcement, and Criminal Investigations

Guidance for Industry

Guidance for Industry

Guidance for Industry

FDA s Final Compliance Policy Guide for Marketed Unapproved Drugs Is Agency Enforcement at a Crossroads, or Stuck in a Traffic Circle

May 5, Dear Mr. Courtney:

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products

Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff

Guidance for Industry Direct-to-Consumer Television Advertisements FDAAA DTC Television Ad Pre- Dissemination Review Program

Billing with National Drug Codes (NDCs) Frequently Asked Questions

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry Classifying Resubmissions in Response to Action Letters

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009

Guidance for Industry

Guidance for Industry DRAFT GUIDANCE

Billing with National Drug Codes (NDCs) Frequently Asked Questions

Medical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image

Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions

Determination of Regulatory Review Period for Purposes of Patent Extension; XARELTO

2014 Annual Report on Inspections of Establishments

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes

Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products

April 10, 2008 Montana Healthcare Programs Update

POLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR. Table of Contents

School of Pharmacy TEMPLE UNIVERSITY

0 EC V-,) 133 Lj9a

Instructions for Completing the Initial System Assessment for Upcoming HIPAA Changes Due Date: (specify date)

RE: NDA: DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER

Determination of Regulatory Review Period for Purposes of Patent Extension;

Standards for the Interoperable Exchange of Information for Tracing of Human, Finished,

Enclosure A DEFINITIONS

Guidance for Industry Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act

January 12, Dear Amy Yang:

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

Guidance for Industry

The 505(b)(2) Drug Development Pathway:

Recommendations from Past Reports: E Prescribing Standards

Guidance for Industry Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification

Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Home Use Medical Device Electronic Labeling - Structured Product Labeling

Guidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.

TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H--MEDICAL DEVICES

CATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity

Request for Quality Metrics Guidance for Industry

Pharmaceutical development is an expensive, time

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

Medical Billing and Agency Formal Disputes

THE FOOD AND DRUG ADMINISTRATION S NATIONAL DRUG CODE DIRECTORY

Prescription Drug Rider

Small Business Assistance

Drug Imports Exports Compliance

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

Hybrid or Mixed Marketing Authorization Application in the European Union: Not a Trivial Decision in New Development Programs for Established Drugs

Cosmetics Regulation in the United States and the European Union:

Combination Products Regulation in the United States

Guidance for Industry

Notes on the architecture, design, and data processes in openfda. processing, data harmonization, and website technologies.

Medical Gas Compliance Alert

Providing Regulatory Submissions In Electronic Format Standardized Study Data

Good Review Practice. October 2009 Labeling

Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration

Compendium service companies assemble and. They add a zero to result in a consistent 11-digit

Active ingredient Stannous fluoride 0.63% w/w (0.19% w/v flouride ion) Purpos e anticavity, antigingivitis, antihypersensitivity, mouthrinse

Frequently Asked Questions

Transcription:

The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. 360)). Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory which is updated daily. 2016

41167-0773-0 Gold Bond Ultimate Hand Sanitizer Moisturizer Labeler Chattem, Inc. of Company corresponding to the labeler code segment of the ProductNDC. NDC Code 41167-0773-0 The labeler code, product code, and package code segments of the National Drug Code number, separated by hyphens. Asterisks are no longer used or included within the product and package code segments to indicate certain configurations of the NDC. Proprietary Gold Bond Ultimate Hand Sanitizer Moisturizer Also known as the trade name. It is the name of the product chosen by the labeler. 11 Digit NDC Code 41167-0773-00 It should be noted that many NDCs are displayed on drug packaging in a 10-digit format. Proper billing of an NDC requires an 11-digit number in a 5-4-2 format. Converting NDCs from a 10-digit to 11-digit format requires a strategically placed zero, dependent upon the 10-digit format. Product NDC 41167-0773 The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. Product Type Non Proprietary Package Description Marketing Category Application Number HUMAN OTC DRUG Benzethonium Chloride 76 g in 1 TUBE (41167-0773-0) OTC MONOGRAPH NOT FINAL part333 Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the Document Type of the SPL submission for the listing. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. Sometimes called the generic name, this is usually the active ingredient(s) of the product. A description of the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. For example: 4 BOTTLES in 1 CARTON/100 TABLETS in 1 BOTTLE. Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. part 341 ). For unapproved drugs, this field will be null. - 2 -

Start Marketing Date 20091115 This is the date that the labeler indicates was the start of its marketing of the drug product. Dosage Form LOTION The translation of the DosageForm Code submitted by the firm. The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. Route TOPICAL The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. Substance BENZETHONIUM CHLORIDE This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. Strength Number.2 These are the strength values (to be used with units below) of each active ingredient, listed in the same order as the Substance field above. Strength Unit g/100g These are the units to be used with the strength values above, listed in the same order as the Substance and SubstanceNumber. - 3 -

Food and Drug Administration Center for Drug Evaluation and Research Office of Compliance, Immediate Office Drug Registration and Listing Team 10903 New Hampshire Ave Silver Spring, MD 20993-0002 Email: edrls@fda.hhs.gov - 4 -

For all questions regarding this bundle please contact Support@HIPAASpace.com. Also feel free to let us know about any suggestions or concerns. All additional information as well as customer support is available at http://www.hipaaspace.com. - 5 -